Antibiotics are medication designed to deal with infections attributable to micro organism (for instance, pores and skin infections). They don’t work on infections attributable to different microbes corresponding to viruses (together with COVID and flu) or fungi (for instance, thrush).
Past treating bacterial infections, antibiotics additionally produce other essential makes use of, like stopping an infection throughout main surgical procedure.
Micro organism have existed for billions of years and are adept at survival. For the reason that early twentieth century when antibiotics have been launched as medicines to combat infections, micro organism have labored out a number of methods to guard themselves and keep away from being killed.
When antibiotics are misused or overused, extra alternatives come up for micro organism to develop and enhance these protecting instruments. This contributes to an issue referred to as antibiotic or antimicrobial resistance, the place micro organism evolve over time in order that antibiotics not work towards them. This makes infections tougher to deal with as medical doctors have fewer antibiotics to select from, in flip rising the danger of great sickness and demise.
However how has the COVID pandemic affected antibiotic use, and the issue of antibiotic resistance? A current research which analysed pharmaceutical gross sales information from 71 international locations means that as COVID instances went up, so did antibiotics gross sales.
The researchers examined gross sales of 4 antibiotic households generally prescribed in respiratory infections (cephalosporins, penicillins, macrolides and tetracyclines) from March 2020 to Could 2022.
They sourced month-to-month gross sales information for these antibiotics per 1,000 folks, and from a separate database additionally gathered information on COVID infections. For comparability, the researchers used international antibiotic gross sales developments from 2018.
Not surprisingly, they discovered antibiotics gross sales fell sharply over April and Could 2020. This drop was seemingly a results of fewer infections spreading whereas folks have been below strict lockdown measures, and maybe some folks avoiding healthcare.
Nonetheless, antibiotic gross sales progressively elevated thereafter. The resurgence of non-COVID respiratory viral infections with the easing of lockdowns could have contributed to elevated antibiotics gross sales from 2021 onward. By Could 2022, gross sales had returned to only under pre-pandemic ranges.
Utilizing statistical fashions, the researchers discovered an affiliation between rising COVID charges and better antibiotic gross sales.
Learn extra:
COVID is attributable to a virus – so why are researchers treating it with antibiotics?
COVID and antibiotics
Analysis has beforehand recognized seasonal spikes in antibiotic use correlating with the winter virus season. That is regarding as a result of antibiotics are designed to focus on micro organism, and haven’t any impact on viruses corresponding to these which trigger colds or flu.
Many antibiotic prescriptions in these instances are inappropriate. Nonetheless, distinguishing viral from bacterial an infection may be tough clinically, particularly within the preliminary levels of an infection. This will clarify why sufferers are generally began on antibiotics whereas ready for laboratory take a look at outcomes.
In sure conditions, antibiotics are applicable. For instance, viral lung infections can harm airways and compromise the conventional protecting immune responses. This will enable micro organism to connect to airway cells and invade, inflicting a secondary bacterial an infection.
Early within the COVID pandemic, antibiotic prescribing was most likely primarily based on earlier expertise with flu, the place charges of secondary bacterial an infection had been reported to be as excessive as 65%. However because the pandemic progressed, information indicated bacterial co-infection in COVID was lower than 10%. Particular antibiotic prescribing tips for sufferers with COVID have been printed.
But regardless of rising proof that bacterial co-infection in COVID is low, analysis has proven antibiotic prescribing amongst COVID sufferers has remained excessive. This newest research gives additional proof that antibiotics are generally prescribed to COVID sufferers.
SofikoS/Shutterstock
Some limitations
Just like different massive research on antibiotic consumption, this research makes use of antibiotic gross sales information as a proxy for antibiotic use. This gross sales information is already captured in databases from quite a few international locations, and is extra readily accessible than information on antibiotic prescriptions in lots of international locations, which might not be captured electronically. However due to the character of the information, we are able to’t draw any conclusions as to how most of the antibiotics bought have been appropriately prescribed.
Additional, information on non-COVID infections, which may impression antibiotic prescribing and charges of resistance, was not included. The pausing of routine childhood vaccination programmes throughout the pandemic most likely elevated bacterial an infection threat in some international locations, necessitating elevated antibiotic prescriptions. This will have contributed to the developments seen.
When deciphering these findings, it’s additionally essential to notice that not all continents have been represented equally. Some massive international locations corresponding to Bangladesh have been excluded.
Lastly, testing protocols differ between international locations, so there could have been some inconsistencies within the COVID case information. And entry to antibiotics is inconsistent globally, particularly in low- and middle-income international locations, which seemingly impacted some international locations’ gross sales charges.
The problem of antibiotic resistance
Antibiotic resistance is a world risk to public well being, impacting people, animals and the atmosphere.
Inappropriate antibiotic prescribing in COVID could possibly be contributing to the issue. To handle this, we have to see extra alignment in tips and protocols for clinicians, particularly linking analysis of viral respiratory infections with antibiotic prescribing tips. Assist for the event of fast diagnostics to substantiate or rule out co-infection would additionally give clinicians confidence to keep away from antibiotics in some sufferers.
Learn extra:
Coronavirus pandemic is paving the way in which for a rise in superbugs
Extra broadly, tackling the difficulty of antibiotic resistance requires elevated public consciousness of the difficulty, enhanced international surveillance of antibiotic use and resistance, improved an infection management insurance policies, and higher sanitation.
This rests on a coordinated “One Well being” strategy – a joint international effort throughout a variety of sectors to offer options for human, animal and environmental well being. This technique ought to handle well being inequalities and would require bespoke interventions, particularly in lower- and middle-income international locations.
